Ray Dalio's INSP Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 173,533 shares of Inspire Medical Systems, Inc. (INSP) worth $8.95 M, representing 0.04% of the portfolio. First purchased in 2021-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in INSP, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 101,806 shares. Largest reduction occurred in Q3 2025, reducing 52,695 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Inspire Medical Systems (INSP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inspire Medical Systems (INSP) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +101,806 | Add 141.94% | 173,533 | $51.58 |
| Q4 2025 | -17,225 | Reduce 19.36% | 71,727 | $92.23 |
| Q3 2025 | -52,695 | Reduce 37.20% | 88,952 | $74.20 |
| Q2 2025 | +68,796 | Add 94.43% | 141,647 | $129.77 |
| Q1 2025 | +69,689 | Add 2203.95% | 72,851 | $159.28 |
| Q4 2024 | -1,378 | Reduce 30.35% | 3,162 | $185.38 |
| Q3 2024 | -752 | Reduce 14.21% | 4,540 | $211.05 |
| Q2 2024 | -527 | Reduce 9.06% | 5,292 | $133.83 |
| Q1 2024 | -1,186 | Reduce 16.93% | 5,819 | $214.79 |
| Q4 2023 | -28,196 | Reduce 80.10% | 7,005 | $203.43 |
| Q3 2023 | +3,636 | Add 11.52% | 35,201 | $198.44 |
| Q2 2023 | -3,594 | Reduce 10.22% | 31,565 | $324.64 |
| Q1 2023 | +1,531 | Add 4.55% | 35,159 | $234.07 |
| Q4 2022 | -11,225 | Reduce 25.03% | 33,628 | $251.88 |
| Q3 2022 | -33,758 | Reduce 42.94% | 44,853 | $177.38 |
| Q2 2022 | +4,209 | Add 5.66% | 78,611 | $182.67 |
| Q1 2022 | +18,775 | Add 33.75% | 74,402 | $256.69 |
| Q4 2021 | +8,207 | Add 17.31% | 55,627 | $230.07 |
| Q3 2021 | -1,622 | Reduce 3.31% | 47,420 | $232.88 |
| Q2 2021 | +45,929 | Add 1475.39% | 49,042 | $193.26 |
| Q1 2021 | +3,113 | New Buy | 3,113 | $206.87 |
Ray Dalio's Inspire Medical Systems Investment FAQs
Ray Dalio first purchased Inspire Medical Systems, Inc. (INSP) in Q1 2021, acquiring 3,113 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Inspire Medical Systems, Inc. (INSP) for 21 quarters since Q1 2021.
Ray Dalio's largest addition to Inspire Medical Systems, Inc. (INSP) was in Q1 2026, adding 173,533 shares worth $8.95 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 173,533 shares of Inspire Medical Systems, Inc. (INSP), valued at approximately $8.95 M.
As of the Q1 2026 filing, Inspire Medical Systems, Inc. (INSP) represents approximately 0.04% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Inspire Medical Systems, Inc. (INSP) was 173,533 shares, as reported at the end of Q1 2026.